Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Long COVID Clinical Trial

— SYNPOCov  

Official title:

Post-Covid Condition Monitoring Cohort: Evaluation of the Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05610436
• Other study ID #: 2022PI148
• Status: Recruiting
• Start date: January 7, 2022
• Est. completion date: June 2026

Study information

• Verified date: October 2022
• Source: Central Hospital, Nancy, France
• Contact: Francois GOEHRINGER, MD
• Phone: +33383154097
• Email: francois.goehringer[@]chru-nancy.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of our cohort is to collect prospectively, in a standardized and exhaustive manner, the health data of patients referred to the CAPCoV, our holistic referal post covid clinics for post-covid condition in order to be able to identify typical profiles of patients suffering from post covid syndrome and to follow the evolution of their disease over time.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: June 2026
• Est. primary completion date: December 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for post-Covid condition according to WHO definition

Exclusion Criteria:

• patient opposing the processing for research purposes of their data collected in routine care for their care

Related Conditions & MeSH terms

• COVID-19
• Long COVID

Locations

Country	Name	City	State
France	Nancy University Hospital	Vandoeuvre les nancy	Grand Est

Sponsors (1)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Symptoms	Symptoms collected in a standardized manner during consultations, their persistence over time, their evolution (improvement, stagnation, worsening) and their severity (mild, moderate, severe)	every 6 months up to 3 years
Secondary	Medical history		baseline
Secondary	fatigue	Chalder scale: range 0 to 33, >22/33 classified severe	every 6 months up to 3 years
Secondary	Dyspnea	mMRC	every 6 months up to 3 years
Secondary	Cognitive impairement	Montréal Cognitive Assessment : range 0 to 30, <26/30 classified pathologic	every 6 months up to 3 years
Secondary	inappropriate hyperventilation syndrome	Nijmegen score: range 0 to 64, >23/34 classified "possible inapropriate hyperventilation" syndrome"	every 6 months up to 3 years
Secondary	additional examinations	Biology, imaging	every 6 months up to 3 years